(Q34308404)

1 August 2017

Ventricular arrhythmias and sudden cardiac death. (English)

1 reference

1 August 2017

4

Christine M Albert

1 reference

1 August 2017

Roy M John

1

1 reference

1 August 2017

Usha B Tedrow

2

1 reference

1 August 2017

Bruce A Koplan

3

1 reference

1 August 2017

Laurence M Epstein

5

1 reference

1 August 2017

Michael O Sweeney

6

1 reference

1 August 2017

Amy Leigh Miller

7

1 reference

1 August 2017

Gregory F Michaud

8

1 reference

1 August 2017

William G Stevenson

9

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 October 2012

1 reference

1 August 2017

10

1 reference

inferred from page(s)

published in

The Lancet

1 reference

1 August 2017

380

1 reference

1 August 2017

9852

1 reference

1 August 2017

1520-1529

1 reference

Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Factors associated with pulseless electric activity versus ventricular fibrillation: the Oregon sudden unexpected death study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Regional variation in out-of-hospital cardiac arrest incidence and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (H

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Clinical practice. Long-QT syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Genetics of sudden death: focus on inherited channelopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

The QT syndromes: long and short

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Trigger-specific ion-channel mechanisms, risk factors, and response to therapy in type 1 long QT syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

High Efficacy of β-Blockers in Long-QT Syndrome Type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Gui

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Clinical and mechanistic issues in early repolarization of normal variants and lethal arrhythmia syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Prevalence and Characteristics of Early Repolarization in the CASPER Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Genetics of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Genetics of inherited cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Clinical consequences of electrocardiographic artifact mimicking ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Prognostic importance of defibrillator shocks in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Arrhythmias originating from the right ventricular outflow tract: how to distinguish "malignant" from "benign"?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Clinical Correlates and Prognostic Significance of Exercise-Induced Ventricular Premature Beats in the Community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Association of electrocardiographic morphology of exercise-induced ventricular arrhythmia with mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Relationship between burden of premature ventricular complexes and left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Electrophysiology-guided defibrillator implantation early after ST-elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Effect of reperfusion time on inducible ventricular tachycardia early and spontaneous ventricular arrhythmias late after ST elevation myocardial infarction treated with primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Defibrillator implantation early after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Cardiac-resynchronization therapy for the prevention of heart-failure events.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Minimizing inappropriate or "unnecessary" implantable cardioverter-defibrillator shocks: appropriate programming

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

The contradiction of appropriate shocks in primary prevention ICDs: increasing and decreasing the risk of death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Determinants of postinfarction ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Ablation of Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Epicardial ablation for ventricular tachycardia: a European multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Coronary artery injury due to catheter ablation in adults: presentations and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Idiopathic ventricular arrhythmias originating from the left ventricular summit: anatomic concepts relevant to ablation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Role of repeat procedures for catheter ablation of postinfarction ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Catheter ablation of electrical storm due to monomorphic ventricular tachycardia in patients with nonischemic cardiomyopathy: acute results and its effect on long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Sustained ventricular tachycardia associated with corrective valve surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Catheter ablation of ventricular tachycardia after left ventricular reconstructive surgery for ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Ventricular tachycardia in the era of ventricular assist devices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Surgical options for refractory ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Surgical ablation of refractory ventricular tachycardia in patients with nonischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Direct transthoracic access to the left ventricle for catheter ablation of ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Hybrid procedures for epicardial catheter ablation of ventricular tachycardia: value of surgical access.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

Noninvasive Identification of Ventricular Tachycardia-Related Conducting Channels Using Contrast-Enhanced Magnetic Resonance Imaging in Patients With Chronic Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961413-5

7 January 2021

10.1016/S0140-6736(12)61413-5

Identifiers

DOI

1 reference

1 August 2017

1 reference